181 related articles for article (PubMed ID: 19915674)
1. Differential role of human choline kinase alpha and beta enzymes in lipid metabolism: implications in cancer onset and treatment.
Gallego-Ortega D; Ramirez de Molina A; Ramos MA; Valdes-Mora F; Barderas MG; Sarmentero-Estrada J; Lacal JC
PLoS One; 2009 Nov; 4(11):e7819. PubMed ID: 19915674
[TBL] [Abstract][Full Text] [Related]
2. Involvement of human choline kinase alpha and beta in carcinogenesis: a different role in lipid metabolism and biological functions.
Gallego-Ortega D; Gómez del Pulgar T; Valdés-Mora F; Cebrián A; Lacal JC
Adv Enzyme Regul; 2011; 51(1):183-94. PubMed ID: 21035492
[TBL] [Abstract][Full Text] [Related]
3. Crystal structures of human choline kinase isoforms in complex with hemicholinium-3: single amino acid near the active site influences inhibitor sensitivity.
Hong BS; Allali-Hassani A; Tempel W; Finerty PJ; Mackenzie F; Dimov S; Vedadi M; Park HW
J Biol Chem; 2010 May; 285(21):16330-40. PubMed ID: 20299452
[TBL] [Abstract][Full Text] [Related]
4. Choline kinase alpha depletion selectively kills tumoral cells.
Bañez-Coronel M; Ramírez de Molina A; Rodríguez-González A; Sarmentero J; Ramos MA; García-Cabezas MA; García-Oroz L; Lacal JC
Curr Cancer Drug Targets; 2008 Dec; 8(8):709-19. PubMed ID: 19075594
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in the design of choline kinase α inhibitors and the molecular basis of their inhibition.
Rubio-Ruiz B; Serrán-Aguilera L; Hurtado-Guerrero R; Conejo-García A
Med Res Rev; 2021 Mar; 41(2):902-927. PubMed ID: 33103259
[TBL] [Abstract][Full Text] [Related]
6. Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells.
Iorio E; Ricci A; Bagnoli M; Pisanu ME; Castellano G; Di Vito M; Venturini E; Glunde K; Bhujwalla ZM; Mezzanzanica D; Canevari S; Podo F
Cancer Res; 2010 Mar; 70(5):2126-35. PubMed ID: 20179205
[TBL] [Abstract][Full Text] [Related]
7. Choline kinase: an important target for cancer.
Janardhan S; Srivani P; Sastry GN
Curr Med Chem; 2006; 13(10):1169-86. PubMed ID: 16719778
[TBL] [Abstract][Full Text] [Related]
8. Choline kinase alpha-Putting the ChoK-hold on tumor metabolism.
Arlauckas SP; Popov AV; Delikatny EJ
Prog Lipid Res; 2016 Jul; 63():28-40. PubMed ID: 27073147
[TBL] [Abstract][Full Text] [Related]
9. Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy.
Ramírez de Molina A; Gutiérrez R; Ramos MA; Silva JM; Silva J; Bonilla F; Sánchez JJ; Lacal JC
Oncogene; 2002 Jun; 21(27):4317-22. PubMed ID: 12082619
[TBL] [Abstract][Full Text] [Related]
10. Generation and characterization of monoclonal antibodies against choline kinase alpha and their potential use as diagnostic tools in cancer.
Gallego-Ortega D; Ramirez De Molina A; Gutierrez R; Ramos MA; Sarmentero J; Cejas P; Nistal M; González Barón M; Lacal JC
Int J Oncol; 2006 Aug; 29(2):335-40. PubMed ID: 16820874
[TBL] [Abstract][Full Text] [Related]
11. Choline kinase-alpha by regulating cell aggressiveness and drug sensitivity is a potential druggable target for ovarian cancer.
Granata A; Nicoletti R; Tinaglia V; De Cecco L; Pisanu ME; Ricci A; Podo F; Canevari S; Iorio E; Bagnoli M; Mezzanzanica D
Br J Cancer; 2014 Jan; 110(2):330-40. PubMed ID: 24281000
[TBL] [Abstract][Full Text] [Related]
12. Near infrared fluorescent imaging of choline kinase alpha expression and inhibition in breast tumors.
Arlauckas SP; Kumar M; Popov AV; Poptani H; Delikatny EJ
Oncotarget; 2017 Mar; 8(10):16518-16530. PubMed ID: 28157707
[TBL] [Abstract][Full Text] [Related]
13. A non-catalytic role of choline kinase alpha is important in promoting cancer cell survival.
Falcon SC; Hudson CS; Huang Y; Mortimore M; Golec JM; Charlton PA; Weber P; Sundaram H
Oncogenesis; 2013; 2(3):e38. PubMed ID: 25522435
[TBL] [Abstract][Full Text] [Related]
14. The phosphoinositide 3-kinase inhibitor PI-103 downregulates choline kinase alpha leading to phosphocholine and total choline decrease detected by magnetic resonance spectroscopy.
Al-Saffar NM; Jackson LE; Raynaud FI; Clarke PA; Ramírez de Molina A; Lacal JC; Workman P; Leach MO
Cancer Res; 2010 Jul; 70(13):5507-17. PubMed ID: 20551061
[TBL] [Abstract][Full Text] [Related]
15. Kinetic and mechanistic characterisation of Choline Kinase-α.
Hudson CS; Knegtel RM; Brown K; Charlton PA; Pollard JR
Biochim Biophys Acta; 2013 Jun; 1834(6):1107-16. PubMed ID: 23416529
[TBL] [Abstract][Full Text] [Related]
16. Anticancer Activity of the Choline Kinase Inhibitor PL48 Is Due to Selective Disruption of Choline Metabolism and Transport Systems in Cancer Cell Lines.
García-Molina P; Sola-Leyva A; Luque-Navarro PM; Laso A; Ríos-Marco P; Ríos A; Lanari D; Torretta A; Parisini E; López-Cara LC; Marco C; Carrasco-Jiménez MP
Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214160
[TBL] [Abstract][Full Text] [Related]
17. Choline kinase as a link connecting phospholipid metabolism and cell cycle regulation: implications in cancer therapy.
Ramírez de Molina A; Gallego-Ortega D; Sarmentero-Estrada J; Lagares D; Gómez Del Pulgar T; Bandrés E; García-Foncillas J; Lacal JC
Int J Biochem Cell Biol; 2008; 40(9):1753-63. PubMed ID: 18296102
[TBL] [Abstract][Full Text] [Related]
18. Preclinical characterization of RSM-932A, a novel anticancer drug targeting the human choline kinase alpha, an enzyme involved in increased lipid metabolism of cancer cells.
Lacal JC; Campos JM
Mol Cancer Ther; 2015 Jan; 14(1):31-9. PubMed ID: 25487918
[TBL] [Abstract][Full Text] [Related]
19. Determination of potential scaffolds for human choline kinase α1 by chemical deconvolution studies.
Sahún-Roncero M; Rubio-Ruíz B; Conejo-García A; Velázquez-Campoy A; Entrena A; Hurtado-Guerrero R
Chembiochem; 2013 Jul; 14(11):1291-5. PubMed ID: 23813777
[TBL] [Abstract][Full Text] [Related]
20. Unusual metal ion cofactor requirement of Entamoeba histolytica choline and ethanolamine kinase isoforms.
Chang CH; Few LL; Lim BH; Yvonne-Tee GB; Chew AL; See Too WC
Parasitol Res; 2023 Jul; 122(7):1651-1661. PubMed ID: 37202563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
